Literature DB >> 22108788

Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.

Julie Scholler1, Yasmine Nivoix, Raoul Herbrecht, Véronique Kemmel, Dominique Levêque.   

Abstract

CASE: We report a case of ventricular bigeminy with concomitant administration of methadone, voriconazole and esomeprazole in a Caucasian woman aged 26 with acute lymphoblastic leukaemia. Plasma concentrations of voriconazole and methadone were high, 12.4 mg/l (therapeutic range: 1-4 mg/l) and 1.6 mg/l (therapeutic range: 0.2-0.4 mg/l), respectively. In the absence of esomeprazole, no more episode of cardiac arrhythmia occurred and 7 days after, methadone plasma concentration fell at 0.57 ml/l while voriconazole concentration was at 5.5 mg/l. We speculate that a pharmacokinetic interaction between methadone and voriconazole was amplified by the addition of esomeprazole. This led to the large increase of the plasma concentration of methadone and was potentially responsible for its cardiac toxicity.
CONCLUSION: Physicians should be aware of the potential interaction between voriconazole, esomeprazole and methadone leading to arrhythmia. The inhibitory potential of voriconazole is possibly increased by esomeprazole.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108788     DOI: 10.1007/s11096-011-9581-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  10 in total

Review 1.  Clinical pharmacokinetics of voriconazole.

Authors:  Dominique Levêque; Yasmine Nivoix; François Jehl; Raoul Herbrecht
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

2.  Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes.

Authors:  A Abelö; T B Andersson; M Antonsson; A K Naudot; I Skånberg; L Weidolf
Journal:  Drug Metab Dispos       Date:  2000-08       Impact factor: 3.922

Review 3.  Arrhythmias associated with fluoroquinolone therapy.

Authors:  Matthew E Falagas; Petros I Rafailidis; Evangelos S Rosmarakis
Journal:  Int J Antimicrob Agents       Date:  2007-01-22       Impact factor: 5.283

4.  Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.

Authors:  Ping Liu; Grover Foster; Robert Labadie; Eugene Somoza; Amarnath Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

5.  Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

Authors:  Xue-Qing Li; Tommy B Andersson; Marie Ahlström; Lars Weidolf
Journal:  Drug Metab Dispos       Date:  2004-08       Impact factor: 3.922

6.  Role of CYP2B6 in stereoselective human methadone metabolism.

Authors:  Rheem A Totah; Pamela Sheffels; Toni Roberts; Dale Whittington; Kenneth Thummel; Evan D Kharasch
Journal:  Anesthesiology       Date:  2008-03       Impact factor: 7.892

Review 7.  Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.

Authors:  Georg B Ehret; Jules A Desmeules; Barbara Broers
Journal:  Expert Opin Drug Saf       Date:  2007-05       Impact factor: 4.250

8.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

9.  Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.

Authors:  Nolan Wood; Keith Tan; Lynn Purkins; Gary Layton; Julia Hamlin; Diane Kleinermans; Don Nichols
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

10.  Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.

Authors:  Seongwook Jeong; Phuong D Nguyen; Zeruesenay Desta
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

  10 in total
  2 in total

Review 1.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

Review 2.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.